Comparisons of the Sensitivity of Histopathological and Immunohistochemical Analyses With Blood Hormone Levels for Early Detection of Antithyroid Effects in Rats Treated With Promoters of Thyroid Hormone Metabolism
Toxicologic Pathology · 2025
DOI: 10.1177/01926233251316880 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Toxicologic Pathology, 2025. Verfasst von Hirotoshi Akane und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pathology, National Institute of Health Sciences, Kawasaki, Japan. Hauptthemen laut MEDLINE: Thyroid Hormones, Thyroid Gland, Hypothyroidism, Antithyroid Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Ministry of Health, Labour and Welfare.
Abstract (Originalsprache)
Although blood triiodothyronine (T3), thyroxine (T4), and thyroid-stimulating hormone (TSH) levels are useful for detecting antithyroid compounds in rodent toxicity studies, there are challenges with high variability due to sampling conditions. Here, we compared histopathological and immunohistochemical findings with blood hormone levels in rats treated with promoters of thyroid hormone metabolism to explore useful markers for hypothyroidism. Six-week-old male and female Sprague-Dawley rats (5/group) were administered phenobarbital sodium salt (NaPB) or nicardipine hydrochloride (NCD) by gavage for 28 days. Decreased serum T4 and increased TSH levels were detected at 100 mg/kg NaPB and 150 mg/kg NCD, whereas follicular cell hypertrophy occurred at lower doses of ≥ 30 mg/kg NaPB and ≥ 50 mg/kg NCD. There was no obvious change in T3 or T4 immunostaining in the thyroid unlike thyroid peroxidase (TPO) inhibitors, and uridine diphosphate-glucuronosyltransferase 1A6-positive area in the liver increased at doses lower than those affecting the serum T4 levels and generally the same as those at which hepatocellular hypertrophy and follicular cell hypertrophy were observed, indicating its usefulness in detecting thyroid hormone metabolism promoters. These results indicate that histopathology is useful for sensitive detection of hormone metabolism promoters and can be distinguished from TPO inhibitors by immunohistochemistry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pathology, National Institute of Health Sciences, Kawasaki, Japan.
- Toxicology Division, Institute of Environmental Toxicology, Joso, Japan.
ORCID-Profile: Takeshi Toyoda, Kohei Matsushita
Förderung
- Ministry of Health, Labour and Welfare
Zitieren
APA
Akane, H., Toyoda, T., Matsushita, K., Uneyama, M., Morikawa, T., Kosaka, T., Tajima, H., Aoyama, H., & Ogawa, K. (2025). Comparisons of the Sensitivity of Histopathological and Immunohistochemical Analyses With Blood Hormone Levels for Early Detection of Antithyroid Effects in Rats Treated With Promoters of Thyroid Hormone Metabolism. Toxicologic Pathology. https://doi.org/10.1177/01926233251316880
Vancouver
Akane H, Toyoda T, Matsushita K, Uneyama M, Morikawa T, Kosaka T, et al. Comparisons of the Sensitivity of Histopathological and Immunohistochemical Analyses With Blood Hormone Levels for Early Detection of Antithyroid Effects in Rats Treated With Promoters of Thyroid Hormone Metabolism. Toxicologic Pathology. 2025. doi:10.1177/01926233251316880
BibTeX
@article{Akane2025,
author = {Akane, Hirotoshi and Toyoda, Takeshi and Matsushita, Kohei and Uneyama, Mizuho and Morikawa, Tomomi and Kosaka, Tadashi and Tajima, Hitoshi and Aoyama, Hiroaki and Ogawa, Kumiko},
title = {Comparisons of the Sensitivity of Histopathological and Immunohistochemical Analyses With Blood Hormone Levels for Early Detection of Antithyroid Effects in Rats Treated With Promoters of Thyroid Hormone Metabolism},
journal = {Toxicologic Pathology},
year = {2025},
doi = {10.1177/01926233251316880}
}
EUVIMED